Synthesis of Lasalocid-Based Bioconjugates and Evaluation of Their Anticancer Activity.
Ontology highlight
ABSTRACT: Using rationally designed bioconjugates is an attractive strategy to develop novel anticancer drugs with enhanced therapeutic potential and minimal side effects compared to the native structures. With respect to the promising activity of lasalocid (LAS) toward various cancer cells, this polyether ionophore seems to be an ideal candidate for bioconjugation. Herein, we describe the synthetic access to a cohort of nine conjugated products of LAS, in which the ionophore biomolecule was successfully combined via covalent bonds with selected anticancer therapeutics or other anticancer active components. The in vitro screening of a series of cancer cell lines allowed us to identify three products with improved anticancer activity profiles compared to those of the starting materials.
SUBMITTER: Antoszczak M
PROVIDER: S-EPMC8771711 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA